UC research finds potential target for tumor-causing condition

November 11, 2019

CINCINNATI -- University of Cincinnati researchers have found additional ways to target the molecular processes involved in activating a certain protein complex to potentially develop new therapies for a tumor-causing disorder.

These findings are being published in the Nov. 11 issue of the journal Nature Metabolism.

"Tuberous sclerosis complex, or TSC, is a genetic disorder that causes tumors to form in many different organs including the brain and affects as many as 50,000 people in the U.S. yearly," says Dr. Chenran Wang, co-corresponding and leading author of the paper and assistant professor in the UC Department of Cancer Biology. "TSC can also affect the brain by causing seizures and autism, among other issues, in newborns and adults. In this condition, the mutations in the genes called Tsc1 or Tsc2 lead to loss of their tumor suppressing functions, which in turn, results in the hyper activation of mTORC1 and its abnormal function, responsible for the multiple symptoms of TSC."

Known as a "master regulator" of cells, mTORC1 is involved in causing the activity of most cell growth; however, it does not promote autophagy -- a regulation method when a cell basically eats itself and an efficient way for fuel generation inside cells.

In this research, scientists saw higher autophagy activity in cells without Tsc1; they then created a "double knockout" animal model -- a model without both Tsc1 and an essential autophagy protein, FIP200, present in the developing nervous system and in adult neural stem cells.

"Using this unique model, we uncovered the essential functions of autophagy as a way to keep mTORC1 activity high and to show the abnormal development of neural stem cells without Tsc1," Wang adds.

Researchers looked at the molecular and metabolic mechanisms of autophagy involved in maintaining high mTORC1 activity and found that it was needed to activate the energy storage, namely lipid droplets in the cells without Tsc.

"The breakdown of lipid droplets by autophagy supplied fatty acid as an energy source to sustain energy production in Tsc1-deficient neural stem cells," Wang says. "We also used pharmacological methods to target autophagy and block fatty acids used to treat defects, mimicking human TSC symptoms in these models."

Co-corresponding author on the study Jun-Lin Guan says these results are key in expanding knowledge of the formation of this disease and how it can be targeted at the molecular level.

"We are now more informed about the signaling pathways and metabolic alterations involved in TSC caused by Tsc gene mutations and overactive mTORC1," says the Francis Brunning Endowed Chair and professor of cancer biology at UC. "This will help in the development of new therapeutic concepts for treatment of patients with this devastating disease."
Other coauthors on the study include Michael Haas, Fuchun Yang, Syn Yeo, Takako Okamoto, Song Chen, Jian Wen, Pranjal Sarma and David Plas.

This research was funded by the National Institute of Neurological Disorders and Stroke and the National Cancer Institute. Researchers cite no conflict of interest.

University of Cincinnati

Related Autophagy Articles from Brightsurf:

Surprising insights into the role of autophagy in neuron
Autophagy protects our neurons in the brain, but for entirely different reasons than previously assumed, as researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Charité in Berlin have shown.

Revealing the identity of the last unknown protein of autophagy
Japanese scientists discovered that Atg9, one of the proteins that function to mediate autophagy, has phospholipid-translocation activity (the lipid scramblase activity) between the two layers of the lipid bilayer?and elucidated that the protein's activity brings about autophagosome membrane expansion.

Lipids, lysosomes, and autophagy: The keys to preventing kidney injury
Lysosomes are cellular waste disposal organelles containing potent enzymes that cause cellular damage if they leak out of ruptured lysosomes.

How zika virus degrades essential protein for neurological development via autophagy
Researchers at the University of Maryland (UMD) shed new light on how Zika virus hijacks our own cellular machinery to break down an essential protein for neurological development, getting it to ''eat itself''.

Autophagy: the beginning of the end
Autophagy, from the Greek for 'self-eating', is an essential process that isolates and recycles cellular components under conditions of stress or when resources are limited.

Cellular cleanup! Atg40 folds the endoplasmic reticulum to facilitate its autophagy
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Institute of Microbial Chemistry investigated 'ER-phagy,' the degradation mechanism of the endoplasmic reticulum (ER), an important organelle with multiple biologically necessary functions like the synthesis of proteins and lipids.

How cells decide the way they want to recycle their content
Researchers from Tokyo Medical and Dental University (TMDU) identified a new phosphorylation site of Ulk1 as a novel regulating mechanism of alternative autophagy.

Autophagy: Scientists discover novel role for self-recycling process in the brain
Proteins classically associated with autophagy regulate the speed of intracellular transport.

Insights into the diagnosis and treatment brain cancer in children
In a recent study published in Autophagy, researchers at Kanazawa University show how abnormalities in a gene called TPR can lead to pediatric brain cancer.

Autophagy degrades liquid droplets, but not aggregates, of proteins
Autophagy is a mechanism through which cellular protein is degraded.

Read More: Autophagy News and Autophagy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.